PNC Financial Services Group’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.5K Buy
1,678
+297
+22% +$3.46K ﹤0.01% 3582
2025
Q1
$10.3K Buy
1,381
+14
+1% +$104 ﹤0.01% 3814
2024
Q4
$8.2K Sell
1,367
-1,625
-54% -$9.74K ﹤0.01% 3867
2024
Q3
$15.3K Sell
2,992
-4,400
-60% -$22.5K ﹤0.01% 3633
2024
Q2
$26.8K Sell
7,392
-2,037
-22% -$7.37K ﹤0.01% 3336
2024
Q1
$30.3K Buy
9,429
+1,615
+21% +$5.18K ﹤0.01% 3235
2023
Q4
$38.3K Sell
7,814
-328
-4% -$1.61K ﹤0.01% 3098
2023
Q3
$44.4K Sell
8,142
-290
-3% -$1.58K ﹤0.01% 3024
2023
Q2
$56.6K Buy
8,432
+1,587
+23% +$10.6K ﹤0.01% 2989
2023
Q1
$60.4K Sell
6,845
-41
-0.6% -$362 ﹤0.01% 2875
2022
Q4
$52.6K Sell
6,886
-1,990
-22% -$15.2K ﹤0.01% 2954
2022
Q3
$64K Buy
8,876
+4,977
+128% +$35.9K ﹤0.01% 2808
2022
Q2
$32K Sell
3,899
-1,394
-26% -$11.4K ﹤0.01% 3245
2022
Q1
$73K Buy
5,293
+3,380
+177% +$46.6K ﹤0.01% 2889
2021
Q4
$53K Sell
1,913
-3,333
-64% -$92.3K ﹤0.01% 3076
2021
Q3
$179K Sell
5,246
-2,472
-32% -$84.3K ﹤0.01% 2266
2021
Q2
$315K Sell
7,718
-2,042
-21% -$83.3K ﹤0.01% 1934
2021
Q1
$393K Sell
9,760
-164
-2% -$6.6K ﹤0.01% 1735
2020
Q4
$588K Buy
9,924
+3,562
+56% +$211K ﹤0.01% 1381
2020
Q3
$309K Sell
6,362
-273
-4% -$13.3K ﹤0.01% 1655
2020
Q2
$322K Buy
6,635
+5,986
+922% +$291K ﹤0.01% 1632
2020
Q1
$18K Buy
649
+11
+2% +$305 ﹤0.01% 3160
2019
Q4
$19K Sell
638
-3
-0.5% -$89 ﹤0.01% 3326
2019
Q3
$20K Buy
+641
New +$20K ﹤0.01% 3341